Research
Investors & Industry
About Us
Ways to Give

Careers
News
Contact

Hutch News

Science Spotlight
News Releases
Scientific Publications
For the Media
Media Coverage

Stories tagged Holly Janes

Results per Page: 20

New Scientific Publications

Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors

3 NEW Week of October 17, 2021

Latest Fred Hutch research on COVID-19

How Hutch scientists have been tackling coronavirus in lab and clinic

Hutch News - September 07, 2021

Tags

Coronavirus COVID-19 Michele Andrasik Vaccine and Infectious Disease CoVPN COVID-19 Prevention Network Holly Janes Leonidas Stamatatos Julie McElrath Andrew McGuire vaccine development antibodies Joshua Schiffer infectious disease modeling Petros Grivas Clinical Research Neelendu Dey microbiome antiviral Elizabeth Duke Laura Matrajt Peter Gilbert biostatistics Jesse Bloom viral evolution Basic Sciences Public Health Sciences Joseph Unger SWOG clinical trials Herbold Computational Biology Program

College students muster for big COVID-19 vaccine study

12,000 participants sought in study to prove if vaccine can block asymptomatic transmission

Hutch News - March 26, 2021

Tags

Lawrence Corey coronavirus COVID-19 COVID-19 Prevention Network Vaccine and Infectious Disease Vaccine Development Holly Janes Elizabeth Brown virology disease prevention

Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’

Summaries of recent Fred Hutch research findings and other news

News Releases - March 02, 2021

Tags

COVID-19 COVID-19 Prevention Network COVID-19 Clinical Research Center COVID positive participants COVID-19 CRC COVID-19 Timeline COVID Research Center Weintraub Graduate Student Award Stanley R Riddell hematopoietic transplant immunotherapy IIRC non-hodgkin lymphoma David G Maloney Damian Green human molecular genetics business development and strategy Hans-Peter Kiem cell and gene therapy gene editing Clinical Research biostatistics Peter Gilbert Holly Janes Jim Kublin Lawrence Corey CoVPN hvtn Public Health Sciences public health Vaccine Development viral infection WHI womens health initiative clinical trials Laura Matrajt

Biostatisticians draft blueprints for COVID-19 vax trials

Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic

Hutch News - February 18, 2021

Tags

Biostatistics Peter Gilbert Holly Janes COVID-19 COVID-19 Prevention Network Jim Kublin Lawrence Corey biostatistics Jessica Andriesen Vaccine Development HVTN CoVPN

HIV vaccine trials are complicated by the availability of PrEP

World AIDS Day 2020: Vaccine researchers still find ways to run trials amid growing use of HIV-prevention drugs

Hutch News - December 01, 2020

Tags

amp hiv prevention study Vaccine and Infectious Disease South African HVTN AIDS Vaccine Early Stage Investigator Programme Seattle HIV Vaccine Trials Unit hiv vaccine VIDD Research Interests bioethics COVID-19 infectious diseases Holly Janes HIV Vaccine Trials Network (HVTN)

The more is not always the merrier

Science Spotlight - October 19, 2015

Tags

HIV AIDS Holly Janes Vaccine and Infectious Disease

Debunking a widely used methodology for assigning importance to biomarkers

Science Spotlight - July 21, 2014

Tags

biomarker Margaret S Pepe Holly Janes Christopher Li Public Health Sciences

Fred Hutchinson Cancer Research Center
Hutch News

Last Modified, April 02, 2020

CONTACT
PARTNERS
SHARED RESOURCES
EMPLOYEE LINKS
SUBSCRIBE TO HUTCH NEWS

Terms of Use & Privacy Policy
Conflict of Interest
Accountability & Impact
Site Map

Fred Hutch is proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.